Proudfoot AE - Search Results

1

Crystallization and preliminary X-ray diffraction studies of recombinant human interleukin-5.

Hassell AM, Wells TN, Graber P, Proudfoot AE, Anderegg RJ, Burkhart W, Jordan SR, Milburn MV. Hassell AM, et al. Among authors: proudfoot ae. J Mol Biol. 1993 Feb 20;229(4):1150-2. doi: 10.1006/jmbi.1993.1110. J Mol Biol. 1993. PMID: 8445640

2

Crystallization and preliminary X-ray diffraction studies of human RANTES.

Shaw JP, Kryger G, Cleasby A, Wonacott A, Power CA, Proudfoot AE, Wells TN. Shaw JP, et al. Among authors: proudfoot ae. J Mol Biol. 1994 Sep 30;242(4):589-90. doi: 10.1006/jmbi.1994.1605. J Mol Biol. 1994. PMID: 7523680

3

Crystallization and preliminary X-ray analysis of Candida albicans phosphomannose isomerase.

Tolley S, Davies G, Hubbard RE, Smith DJ, Proudfoot AE, Payton MA, Cleasby A, Wonacott A, Wells TN. Tolley S, et al. Among authors: proudfoot ae. J Mol Biol. 1994 Apr 1;237(3):349-50. doi: 10.1006/jmbi.1994.1235. J Mol Biol. 1994. PMID: 8145246

4

Purification, characterisation and crystallisation of selenomethionyl recombinant human interleukin-5 from Escherichia coli.

Graber P, Bernard AR, Hassell AM, Milburn MV, Jordan SR, Proudfoot AE, Fattah D, Wells TN. Graber P, et al. Among authors: proudfoot ae. Eur J Biochem. 1993 Mar 15;212(3):751-5. doi: 10.1111/j.1432-1033.1993.tb17714.x. Eur J Biochem. 1993. PMID: 8462547 Free article.

5

Human interleukin-5 expressed in Escherichia coli has N-terminal modifications.

Rose K, Regamey PO, Anderegg R, Wells TN, Proudfoot AE. Rose K, et al. Among authors: proudfoot ae. Biochem J. 1992 Sep 15;286 ( Pt 3)(Pt 3):825-8. doi: 10.1042/bj2860825. Biochem J. 1992. PMID: 1417743 Free PMC article.

6

Inhibition of phosphomannose isomerase by mercury ions.

Wells TN, Payton MA, Proudfoot AE. Wells TN, et al. Among authors: proudfoot ae. Biochemistry. 1994 Jun 21;33(24):7641-6. doi: 10.1021/bi00190a018. Biochemistry. 1994. PMID: 8011630

7

The three-dimensional structure of human interleukin-5 at 2.4-angstroms resolution: implication for the structures of other cytokines.

Wells TN, Graber P, Proudfoot AE, Arod CY, Jordan SR, Lambert MH, Hassel AM, Milburn MV. Wells TN, et al. Among authors: proudfoot ae. Ann N Y Acad Sci. 1994 May 28;725:118-27. doi: 10.1111/j.1749-6632.1994.tb39796.x. Ann N Y Acad Sci. 1994. PMID: 8030983 No abstract available.

8

A novel dimer configuration revealed by the crystal structure at 2.4 A resolution of human interleukin-5.

Milburn MV, Hassell AM, Lambert MH, Jordan SR, Proudfoot AE, Graber P, Wells TN. Milburn MV, et al. Among authors: proudfoot ae. Nature. 1993 May 13;363(6425):172-6. doi: 10.1038/363172a0. Nature. 1993. PMID: 8483502

9

The carboxy-terminal region of human interleukin-5 is essential for maintenance of tertiary structure but not for dimerization.

Proudfoot AE, Brown SC, Graber P, Talabot F, Arod CY, Peitsch MC, Banks M, McKinnon M, Solari R, Wells TN. Proudfoot AE, et al. J Protein Chem. 1996 Jul;15(5):491-9. doi: 10.1007/BF01886857. J Protein Chem. 1996. PMID: 8895095

10

Soluble interleukin-5 receptor alpha-chain binding assays: use for screening and analysis of interleukin-5 mutants.

Banks M, Graber P, Proudfoot AE, Arod CY, Allet B, Bernard AR, Sebille E, McKinnon M, Wells TN, Solari R. Banks M, et al. Among authors: proudfoot ae. Anal Biochem. 1995 Sep 20;230(2):321-8. doi: 10.1006/abio.1995.1481. Anal Biochem. 1995. PMID: 7503425

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

237 results

Search Page

Filters